Goldswain, H., Dong, X., Penrice-Randal, R., Alruwaili, M., Shawli, G., Prince, T., . . . Investigators, I. (2023). The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection. BioMed Central.
Chicago Style (17th ed.) CitationGoldswain, H., et al. The P323L Substitution in the SARS-CoV-2 Polymerase (NSP12) Confers a Selective Advantage During Infection. BioMed Central, 2023.
MLA (9th ed.) CitationGoldswain, H., et al. The P323L Substitution in the SARS-CoV-2 Polymerase (NSP12) Confers a Selective Advantage During Infection. BioMed Central, 2023.
Warning: These citations may not always be 100% accurate.